埃索美拉唑联合胸腺蛋白口服液治疗消化性溃疡疗效观察

The Clinical Observation of the Medical Treatment for Peptic Ulcer with the Combination of Both Esomeprazole and Thymus Protein Oral Solution

目的探索埃索美拉唑联合胸腺蛋白口服液对消化腺溃疡的疗效。方法将102例患者随机分为治疗组与对照组,对照组服用埃索美拉唑,治疗组加用胸腺蛋白口服液,疗效均4周。结果 2组治疗后总愈合率及总有效率均显著高于对照组(P<0.05)。结论与单纯服用埃索美拉唑相比,两者联合治疗疗效确切,复发率低,愈合质量提高。

Objective This research mainly explores the therapeutic effect of the Esomeprazole pills combined with Thymus Protein Oral Solution for Peptic Ulcer.Methods To achieve this goal,the writer randomly divides 102 cases into the experimental group and the control group.The control group only take the Esomeprazole pills,while the experimental group also take the Thymus Protein Oral Solution besides the Esomeprazole pills.Results The medical treatment of both groups lasts 4 weeks.After the treatment,the total healing rate and the total effective rate in the experimental group are both significantly higher than those in the control group （P〈0.05）.Conclusion Therefore,such a conclusion can be drawn：Compared with simply taking the Esomeprazole pills,the therapeutic effect of the combination of both the Esomeprazole pills and the Thymus Protein Oral Solution is obvious.What is more,the relapse rate is low,and the healing quality is also improved.